Housey Pharma

Housey Pharma is a biotechnology company specializing in the discovery and development of small-molecule therapeutics using proprietary cell-based assay technologies. The company's core platform, Housey Cell-Based Assay Technology (H-CAT), enables the identification of compounds that interact with specific protein targets in their natural cellular environment. Housey Pharma's internal research programs are primarily focused on oncology, metabolic diseases such as type 2 diabetes, and inflammatory disorders. In addition to its internal pipeline, the company licenses its foundational drug discovery patents to major global pharmaceutical corporations. Based in Southfield, Michigan, the company was founded by Dr. Gerard Housey to advance targeted drug discovery and personalized medicine.